| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF00194404 |
| P698 | PubMed publication ID | 7957521 |
| P2093 | author name string | J M Scherrmann | |
| C Girre | |||
| A Sabouraud | |||
| M Rochdi | |||
| R Venet | |||
| P2860 | cites work | Pharmacokinetics/bioavailability of colchicine in healthy male volunteers | Q69462567 |
| Treatment of pustulosis palmaris et plantaris with oral doses of colchicine | Q70391708 | ||
| A fatal overdose with colchicine | Q71336524 | ||
| A sensitive radioimmunoassay for colchicine | Q72457591 | ||
| Colchicine in acute gout. Reassessment of risks and benefits | Q39803879 | ||
| Colchicine kinetics in patients with familial Mediterranean fever | Q40860347 | ||
| Estimation of Colchicine in a Poisoned Patient by Using High Performance Liquid Chromatography | Q41731593 | ||
| Colchicine in the treatment of cirrhosis of the liver | Q49172380 | ||
| Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. | Q52795932 | ||
| Application of the Wagner-Nelson absorption method to the two-compartment open model. | Q52888158 | ||
| Zero-order absorption and linear disposition of oral colchicine in healthy volunteers. | Q54117336 | ||
| Colc hicine treatment of Behqet's disease in children | Q61628572 | ||
| Long-term evaluation of colchicine in the treatment of scleroderma | Q66986224 | ||
| Long-term colchicine prophylaxis in familial Mediterranean fever | Q67692370 | ||
| Radioimmunoassay for colchicine in plasma and urine | Q67749819 | ||
| Model-independent pharmacokinetics of colchicine after oral administration to healthy volunteers | Q69417210 | ||
| P433 | issue | 4 | |
| P921 | main subject | pharmacokinetics | Q323936 |
| (S)-(−)-colchicine | Q326224 | ||
| bioavailability | Q461809 | ||
| P304 | page(s) | 351-354 | |
| P577 | publication date | 1994-01-01 | |
| P1433 | published in | European Journal of Clinical Pharmacology | Q1376707 |
| P1476 | title | Pharmacokinetics and absolute bioavailability of colchicine after i.v. and oral administration in healthy human volunteers and elderly subjects | |
| P478 | volume | 46 |
| Q58093410 | A rare case report of heavy dose colchicine induced acute kidney injury |
| Q46306823 | Body fluid and tissue analysis using filter paper sampling support prior to LC-MS/MS: application to fatal overdose with colchicine |
| Q31823206 | Colchicine and griseofulvin inhibit VCAM-1 expression on human vascular endothelial cells - evidence for the association of VCAM-1 expression with microtubules |
| Q34152073 | Colchicine in clinical medicine. A guide for internists |
| Q38794974 | Colchicine induces autophagy and senescence in lung cancer cells at clinically admissible concentration: potential use of colchicine in combination with autophagy inhibitor in cancer therapy |
| Q36384995 | Colchicine: old and new |
| Q97521410 | Current Therapeutic Options for the Main Monogenic Autoinflammatory Diseases and PFAPA Syndrome: Evidence-Based Approach and Proposal of a Practical Guide |
| Q34034360 | Geropharmacology for the rheumatologist |
| Q44946713 | Grapefruit juice and its constituents augment colchicine intestinal absorption: potential hazardous interaction and the role of p-glycoprotein |
| Q40920731 | Pharmacology of immunosuppressive medications used in renal diseases and transplantation |
| Q73301280 | Recent advances in pharmacokinetics in elderly |
| Q89070238 | Suppression of detyrosinated microtubules improves cardiomyocyte function in human heart failure |
| Q33998011 | Tetraparesis associated with colchicine is probably due to inhibition by verapamil of the P-glycoprotein efflux pump in the blood-brain barrier |
| Q28217460 | Update on colchicine and its mechanism of action |
Search more.